Renee A ButlerinPharm-OlamRecent Milestones in Rare Cancer ResearchCancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer happened in 1903…May 5, 2021May 5, 2021
Renee A ButlerinPharm-Olam8 Strategies for Navigating Clinical Studies During COVID-19 | Pharm-OlamCOVID-19 has presented a variety of challenges. The way people live their lives and conduct their work has been disrupted. There are…Mar 17, 2021Mar 17, 2021
Renee A ButlerinPharm-OlamRisk Management: Foundation for Better Project Management | Pharm-OlamRisk assessments are often an afterthought. A company is required to be audited, and the auditor finds gaps or holes in its processes. That…Jan 20, 2021Jan 20, 2021
Renee A ButlerinPharm-OlamWhat is the Difference Between Microbiome and Microbiota?Medicine is continually advancing. New bodily mechanisms are uncovered and understood as analytical platforms improve. It happens almost by…Jan 13, 2021Jan 13, 2021
Renee A ButlerinPharm-OlamUnderstanding the Connection Between COVID-19 and VAPVentilator-Associated Pneumonia (VAP) is a common complication of mechanical ventilation. Overall, the percentage of VAP or cases of…Jan 6, 2021Jan 6, 2021
Renee A ButlerinPharm-OlamImportance of Natural History Study to Rare Disease Drug DevelopmentRare disease drug development varies from the pathways seen in more established indications. The sample sizes are often extremely small…Dec 30, 2020Dec 30, 2020
Renee A ButlerinPharm-Olam5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical TrialsPersonal data privacy has taken another evolutionary step with the release of the Regulation (EU) 2016/679 of the European Parliament and…Dec 23, 2020Dec 23, 2020
Renee A ButlerinPharm-OlamUnderstanding the 3 Types of Clinical Trial MonitoringClinical trials continue to evolve and so do the methodologies used to support and provide the vital clinical trial monitoring necessary to…Nov 25, 20201Nov 25, 20201
Renee A ButlerinPharm-OlamCompleting a Rescue Study Transition — How Much Time Do You Need?Clinical trials are large complex projects, and occasionally a sponsor may need to make a change to bring an underperforming project back…Nov 11, 2020Nov 11, 2020
Renee A ButlerinPharm-OlamEffective Cohort Management in Early Phase Oncology TrialsCohort management is part and parcel of conducting dose-escalation studies, but not all teams effectively manage it. Pharm-Olam is focused…Nov 4, 2020Nov 4, 2020